Comments
Loading...
Accolade (ACCD) Forecast
NewsEarningsAccolade (ACCD) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAccolade (NASDAQ:ACCD) Stock Quotes, Forecast and News Summary
Accolade Stock (NASDAQ: ACCD) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Accolade (ACCD) stock?
You can purchase shares of Accolade (NASDAQ:ACCD) through any online brokerage.
Who are Accolade (ACCD) competitors?
Other companies in Accolade’s space includes: Prenetics Global (NASDAQ:PRE), Cross Country Healthcare (NASDAQ:CCRN), Talkspace (NASDAQ:TALK), EUDA Health Holdings (NASDAQ:EUDA) and InnovAge Holding (NASDAQ:INNV).
What is the forecast, or price target, for Accolade (ACCD) stock?
Accolade has a consensus price target of $11.91.
What is the current price for Accolade (ACCD)?
The stock price for Accolade (NASDAQ: ACCD) is $3.635 last updated November 21, 2024 at 1:26 PM EST.
Does Accolade (ACCD) pay a dividend?
There are no upcoming dividends for Accolade.
When is Accolade (NASDAQ:ACCD) reporting earnings?
Accolade’s Q3 earnings are confirmed for Monday, January 6, 2025.
Is Accolade (ACCD) going to split?
There is no upcoming split for Accolade.
What sector and industry does Accolade (ACCD) operate in?
Accolade is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.